JPWO2023057758A5 - - Google Patents

Info

Publication number
JPWO2023057758A5
JPWO2023057758A5 JP2024521039A JP2024521039A JPWO2023057758A5 JP WO2023057758 A5 JPWO2023057758 A5 JP WO2023057758A5 JP 2024521039 A JP2024521039 A JP 2024521039A JP 2024521039 A JP2024521039 A JP 2024521039A JP WO2023057758 A5 JPWO2023057758 A5 JP WO2023057758A5
Authority
JP
Japan
Prior art keywords
drug conjugate
pharmaceutically acceptable
acceptable salt
linker
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521039A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536413A (ja
JP2024536413A5 (https=
Publication date
Priority claimed from GBGB2114279.9A external-priority patent/GB202114279D0/en
Application filed filed Critical
Publication of JP2024536413A publication Critical patent/JP2024536413A/ja
Publication of JPWO2023057758A5 publication Critical patent/JPWO2023057758A5/ja
Publication of JP2024536413A5 publication Critical patent/JP2024536413A5/ja
Pending legal-status Critical Current

Links

JP2024521039A 2021-10-06 2022-10-06 二環式ペプチドリガンド薬物コンジュゲート Pending JP2024536413A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2114279.9A GB202114279D0 (en) 2021-10-06 2021-10-06 Bicyclic peptide ligand drug conjugates
GB2114279.9 2021-10-06
PCT/GB2022/052524 WO2023057758A1 (en) 2021-10-06 2022-10-06 Bicyclic peptide ligand drug conjugates

Publications (3)

Publication Number Publication Date
JP2024536413A JP2024536413A (ja) 2024-10-04
JPWO2023057758A5 true JPWO2023057758A5 (https=) 2025-10-15
JP2024536413A5 JP2024536413A5 (https=) 2025-10-15

Family

ID=78497713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521039A Pending JP2024536413A (ja) 2021-10-06 2022-10-06 二環式ペプチドリガンド薬物コンジュゲート

Country Status (6)

Country Link
US (1) US20240398965A1 (https=)
EP (1) EP4412657A1 (https=)
JP (1) JP2024536413A (https=)
CN (1) CN118215505A (https=)
GB (1) GB202114279D0 (https=)
WO (1) WO2023057758A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
IL279489B2 (en) * 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201914872D0 (en) * 2019-10-15 2019-11-27 Bicycletx Ltd Bicyclic peptide ligand drug conjugates

Similar Documents

Publication Publication Date Title
JP2020073481A5 (https=)
TWI221845B (en) Peptide analogues
EP0181001B1 (en) Polypeptide, a process for preparing the same, a pharmaceutical composition containing said polypeptide as well as the use thereof
US20220411461A1 (en) Methods of making incretin analogs
AU2012326026A1 (en) Peptidomimetic macrocyles
ES2375038T3 (es) Derivados de metastina y su uso.
WO2011038066A4 (en) Novel npr-b agonists
JPWO2021074622A5 (https=)
TW202140513A (zh) 人類運鐵蛋白受體結合肽
JPWO2020120984A5 (https=)
JP2024520234A (ja) Psd-95阻害剤及びその使用
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
JP2024507795A (ja) グルカゴン様ペプチド-1受容体アンタゴニスト
JPWO2022026629A5 (https=)
JP2004513079A (ja) 鎮痛性ペプチドを含んでなる薬剤組成物
EP3096795B1 (en) Activated neurotensin molecules and the uses thereof
JPWO2023057758A5 (https=)
JPH0592996A (ja) 心房性ナトリウム利尿因子活性をもつペプチド
JPWO2020028254A5 (https=)
HU205771B (en) Process for producing irreversible peptide ligands for bombesin receptors and process for producing pharmaceutical compositions comprising such peptides as active ingredient
JP2009519945A5 (https=)
EP0431113A1 (en) Atrial peptide derivatives
HU177133B (en) Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity
HU177134B (en) Process for preparing angiotensin ii analogues containing alpha-hydroxy-acid in position 1 with angiotensin ii antagonist activity
DE69403110T2 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen